Videos and webinars

  1. Emerging Technologies In Cell Therapy Manufacturing: Embracing Automation, Robotics, And AI 4/15/2025

    In this segment of our Cell & Gene Live, expert panelists Rohit Ingale, Head of Manufacturing & MSAT, Arcellx and David O’Donnell, Vice President, Head of Manufacturing, Vor Bio define innovation as benefiting patients and emphasize automation and robotics as central to the cause.

  2. Cell Therapy's Current Manufacturing Challenges 4/15/2025

    In this segment, Cell & Gene’s Chief Editor, Erin Harris, welcomes the audience and introduces the expert panelists, Rohit Ingale, Head of Manufacturing & MSAT, Arcellx and David O’Donnell, Vice President, Head of Manufacturing, Vor Bio.

  3. MicroCNX Nano Series Connectors Assembly Overview 2/28/2025

    Maintaining sterility is crucial, even in uncontrolled spaces. Learn how this innovative, miniature connector allows you to establish aseptic connections for 1/16" and 1/8" tubing, anywhere you need them.

  4. MicroCNX® Series Connectors: Introducing The MicroCNX ULT And MicroCNX Luer 9/23/2024

    Experience the future of connectivity. Designed for enhanced simplicity and productivity, these innovative connectors are perfect for cell therapies requiring cryogenic freezing and sterile connections.

  5. Point-Of-Care, Decentralized CAR-T Manufacturing 9/13/2024

    In this Cell & Gene Live segment, our panelists deliberate on the feasibility of decentralized, point-of-care CAR-T manufacturing and highlight the common concerns and challenges associated with POC manufacturing.

  6. Vector Manufacturing 9/13/2024

    In this segment, Cartesian Therapeutics SVP and head of manufacturing operations, Emily English, Ph.D., explains the company’s unique mRNA-based approach to CAR-T manufacturing.

  7. Making Changes To The Product 9/13/2024

    In this segment from the Cell & Gene Live! Event Modernizing CAR-T Manufacturing: Is Point Of Care The Future?, former FDA CMC expert-turned consultant at Dark Horse, Tal Salz, Ph.D., answers an audience question about making changes to CGT products and the regulatory considerations this entails.

  8. Increasing The CGT Field's Investment In Innovation 9/13/2024

    In this segment from the Cell & Gene Live! Event Modernizing CAR-T Manufacturing: Is Point Of Care The Future?, our expert panelists respond to an audience question about how the industry can increase investment in the field’s innovation.

  9. Improving Vein-to-Vein Time 9/13/2024

    Panelists discuss the work being done to shorten the manufacturing process for autologous CAR-T products and the biological and technological constraints around production.

  10. Improving Scalability And Manufacturing Capacity 9/13/2024

    Due to the bespoke nature of autologous CAR-T manufacturing facilities can only produce so many therapies at once. Our panelists discuss inherent cell therapy manufacturing challenges and the need for innovative solutions.